Novartis keeps CEO pay steady, but incoming chairman pay drops
BASEL (Reuters) - Novartis kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards.
Related Articles
- Exclusive: Activist investor Sandell urges swap on DCP Midstream also published in Chicago Tribune
- 20 Taiwan Businesspeople To Watch -- James Kuo, Austin Liu and Andy Lu also categorized in BoardNews
- The Other Duty of Corporate Governance also categorized in BoardNews
- Exclusive: Proxy firm Egan-Jones Withdraws Recommendation on Tempur Sealy also written by Reuters
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews
- Coca-Cola Faces Renewed Pressure Over Executive Pay also written by Reuters
- AIG Chairman Steve Miller to Step Down in July also written by Reuters
- Germany's Corporate Governance Problem also categorized in BoardNews
- Two Shareholders Sue American Apparel Over CEO's Ouster also written by Reuters
Login to comment.